Company Registration No. 04209709 (England and Wales)
EAST AND WEST HEALTHCARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025
EAST AND WEST HEALTHCARE LIMITED
COMPANY INFORMATION
Directors
Miss N Choudhry
Miss N Ali
Miss R Khan
Company number
04209709
Registered office
The Mews Nursing Home
Fenton Street
Rochdale
England
OL11 3TH
Auditor
Rogers Spencer
Newstead House
Pelham Road
Nottingham
NG5 1AP
EAST AND WEST HEALTHCARE LIMITED
CONTENTS
Page
Directors' report
1
Directors' responsibilities statement
2
Strategic report
3 - 4
Independent auditor's report
5 - 8
Profit and loss account
9
Statement of comprehensive income
10
Balance sheet
13
Statement of changes in equity
11
Statement of cash flows
12
Notes to the financial statements
14 - 23
EAST AND WEST HEALTHCARE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MAY 2025
- 1 -

The directors present their annual report and financial statements for the year ended 31 May 2025.

Results and dividends

The results for the year are set out on page 9.

Ordinary dividends were paid amounting to £340,000. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Miss N Choudhry
Miss N Ali
Miss R Khan
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

On behalf of the board
Miss R Khan
Director
29 May 2026
EAST AND WEST HEALTHCARE LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 MAY 2025
- 2 -

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

EAST AND WEST HEALTHCARE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 MAY 2025
- 3 -

The directors present the strategic report for the year ended 31 May 2025.

Principal activities
The principal activity of the company is that of the provision of residential nursing health care for the elderly.
Review of the business

Turnover 2025: £8,005,071 (2024: £7, 452,444) - increase of 7% from last year

Cost of sales 2025: £313,624 ( 2024: £324,432) – decrease of 3% from last year

Profit before tax 2025: £669,323 (2024: £269,426) – increase 148% from last year

Bank debt over 1 year 2025:

The business profitability has seen an increase from previous year, this is due to increased profit in Braeside which previously showed a loss but under new management has seen occupancies levels that the home achieved pre covid. Roche abbey is still showing a loss however this has been significant reduced to £31,000 over the year.

The company has successful cut its agency bill and this effort will continue into the next year. The recruitment from abroad has been instrumental in helping cut the agency bill and this has allowed us to stabilise the staff in the homes and these staff members are responsible for picking up additional shits in the case of sickness and holidays cutting the need to use agency.

Staffing has been reevaluated to ensure that the homes are staffed to the dependency levels and there is no additional staff, this has helped to counter act the effects of the increase in Employer National Insurance. We have particularly cut the hours worked by domestic staff and kitchen assistants. These efforts will continue in the future.

The business refinanced at 2.1% above base rate with Barclays bank which is better than the previous rate with Virgin Money.

The increase from the council for the following year is likely to only cover the increase in minimum wage for employees the company will continue to look for ways to reduce the wage bill while ensuring safe levels of care.

Fair review of the business

The profitability of the company doubled from last year, we have managed to reduce the agency bill by £166,000 and this effort will continue to reduce further. Focus will be on Roche abbey occupancy to ensure that the home is not losing money going forward. We have a stable management in place for Roche abbey and the home has increased it’s CQC rating from Requires Improvement to good, this should support better occupancy for the home going forward.

Energy prices have stablised however they are still higher than pre covid prices and we are unlikely to see the market returning to those prices going forward. Insurance for the homes continues to be much higher than pre covid however we will look to find new insurers in an attempt to bring these costs down.

Braeside will require some capital expenditure on the roof and windows, and the extension which is likely to impact overall profitability of the home over the next two years.

Principal risks and uncertainties

Risks going forward are likely to be the demand for residential and nursing care as the councils are promoting a home first policy which may lead to longer times to fill beds and service user’s being of higher dependency when coming to the home. We are looking at how we can diversify the services offered in the homes, potentially offering complex care which would attract a higher fee.

EAST AND WEST HEALTHCARE LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 4 -

On behalf of the board

Miss R Khan
Director
29 May 2026
EAST AND WEST HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF EAST AND WEST HEALTHCARE LIMITED
- 5 -
Opinion

We have audited the financial statements of East and West Healthcare Limited (the 'company') for the year ended 31 May 2025 which comprise the profit and loss account, the statement of comprehensive income, the balance sheet, the statement of changes in equity, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Emphasis of matter

We draw your attention to note 10 in the financial statements which describes uncertainty of the valuation of the property at the carrying value of £5,000,000.

 

We do not modify our opinion with regard to this matter.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

EAST AND WEST HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF EAST AND WEST HEALTHCARE LIMITED (CONTINUED)
- 6 -

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

EAST AND WEST HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF EAST AND WEST HEALTHCARE LIMITED (CONTINUED)
- 7 -

The extent to which the audit was considered capable of detecting irregularities including fraud

Our approach to identifying and assessing the risk of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

To address the risk of fraud through management bias and override of controls, we:

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

EAST AND WEST HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF EAST AND WEST HEALTHCARE LIMITED (CONTINUED)
- 8 -

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Alistair Allcock (Senior Statutory Auditor)
For and on behalf of Rogers Spencer, Statutory Auditor
Chartered Accountants
Newstead House
Pelham Road
Nottingham
NG5 1AP
29 May 2026
EAST AND WEST HEALTHCARE LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MAY 2025
- 9 -
2025
2024
Notes
£
£
Turnover
3
8,005,071
7,452,445
Cost of sales
(313,624)
(324,432)
Gross profit
7,691,447
7,128,013
Administrative expenses
(6,901,966)
(6,721,065)
Other operating income
2,847
23,888
Operating profit
4
792,328
430,836
Interest payable and similar expenses
7
(123,005)
(161,410)
Profit before taxation
669,323
269,426
Tax on profit
8
(174,893)
(67,416)
Profit for the financial year
494,430
202,010

The profit and loss account has been prepared on the basis that all operations are continuing operations.

EAST AND WEST HEALTHCARE LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MAY 2025
- 10 -
2025
2024
£
£
Profit for the year
494,430
202,010
Other comprehensive income
Revaluation of tangible fixed assets
-
0
(926,592)
Tax relating to other comprehensive income
-
0
231,649
Total other comprehensive income for the year
-
0
(694,943)
Total comprehensive income for the year
494,430
(492,933)
EAST AND WEST HEALTHCARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MAY 2025
- 11 -
Share capital
Share premium account
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
£
Balance at 1 June 2023
16,500
464,000
1,902,835
1,628,329
4,011,664
Year ended 31 May 2024:
Profit
-
-
-
202,010
202,010
Other comprehensive income:
Revaluation of tangible fixed assets
-
-
(926,592)
-
(926,592)
Tax relating to other comprehensive income
-
-
231,649
-
0
231,649
Total comprehensive income
-
-
(694,943)
202,010
(492,933)
Balance at 31 May 2024
16,500
464,000
1,207,892
1,830,339
3,518,731
Year ended 31 May 2025:
Profit and total comprehensive income
-
-
-
494,430
494,430
Dividends
9
-
-
-
(340,000)
(340,000)
Balance at 31 May 2025
16,500
464,000
1,207,892
1,984,769
3,673,161
EAST AND WEST HEALTHCARE LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MAY 2025
- 12 -
2025
2024
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
21
1,072,393
242,870
Interest paid
(123,005)
(161,410)
Income taxes paid
(27,040)
(138,029)
Net cash inflow/(outflow) from operating activities
922,348
(56,569)
Investing activities
Purchase of tangible fixed assets
(74,097)
(76,022)
Net cash used in investing activities
(74,097)
(76,022)
Financing activities
Repayment of bank loans
(63,552)
(107,610)
Dividends paid
(340,000)
-
0
Net cash used in financing activities
(403,552)
(107,610)
Net increase/(decrease) in cash and cash equivalents
444,699
(240,201)
Cash and cash equivalents at beginning of year
570,416
810,617
Cash and cash equivalents at end of year
1,015,115
570,416
EAST AND WEST HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 MAY 2025
31 May 2025
- 13 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
10
5,219,868
5,237,780
Current assets
Stocks
11
9,165
9,421
Debtors
12
941,720
1,171,325
Cash at bank and in hand
1,015,115
570,416
1,966,000
1,751,162
Creditors: amounts falling due within one year
13
(1,646,161)
(1,784,879)
Net current assets/(liabilities)
319,839
(33,717)
Total assets less current liabilities
5,539,707
5,204,063
Creditors: amounts falling due after more than one year
14
(1,428,142)
(1,242,078)
Provisions for liabilities
Deferred tax liability
16
438,404
443,254
(438,404)
(443,254)
Net assets
3,673,161
3,518,731
Capital and reserves
Called up share capital
18
16,500
16,500
Share premium account
464,000
464,000
Revaluation reserve
1,207,892
1,207,892
Profit and loss reserves
1,984,769
1,830,339
Total equity
3,673,161
3,518,731

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 29 May 2026 and are signed on its behalf by:
Miss R Khan
Director
Company registration number 04209709 (England and Wales)
EAST AND WEST HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2025
- 14 -
1
Accounting policies
Company information

East and West Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is The Mews Nursing Home, Fenton Street, Rochdale, England, OL11 3TH.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings Freehold
No depreciation
Fixtures, fittings & equipment
15% straight line & 25% straight line
Motor vehicles
25% straight line

In the opinion of the directors, in order for the accounts to show a true and fair view, no depreciation is charged in respect of freehold land and buildings.

1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price.

1.7
Financial instruments
EAST AND WEST HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 15 -
Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

EAST AND WEST HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 16 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.13
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

EAST AND WEST HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
1
Accounting policies
(Continued)
- 17 -
1.14
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Turnover and other revenue
2025
2024
£
£
Turnover analysed by class of business
Residential nursing health care
8,005,071
7,452,445
2025
2024
£
£
Turnover analysed by geographical market
United Kingdom
8,005,071
7,452,445
2025
2024
£
£
Other revenue
Grants received
2,847
23,888
4
Operating profit
2025
2024
Operating profit for the year is stated after charging/(crediting):
£
£
Government grants
(2,847)
(23,888)
Depreciation of tangible fixed assets
92,009
91,492
Operating lease charges
-
1,930
EAST AND WEST HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 18 -
5
Auditor's remuneration
2025
2024
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the company
17,400
8,980
6
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
228
242

Their aggregate remuneration comprised:

2025
2024
£
£
Wages and salaries
5,580,495
5,188,787
Pension costs
80,507
64,425
5,661,002
5,253,212
7
Interest payable and similar expenses
2025
2024
£
£
Interest on financial liabilities measured at amortised cost
Interest on bank overdrafts and loans
123,005
121,603
Other finance costs
Other interest
-
0
39,807
123,005
161,410
8
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
179,743
67,152
Deferred tax
Origination and reversal of timing differences
(4,850)
264
Total tax charge
174,893
67,416
EAST AND WEST HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
8
Taxation
(Continued)
- 19 -

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2025
2024
£
£
Profit before taxation
669,323
269,426
Expected tax charge based on the standard rate of corporation tax in the UK of 25% (2024: 25%)
167,331
67,357
Effects of:
Expenses that are not deductible in determining taxable profit
7,739
-
0
Other non-reversing timing differences
(177)
-
0
Tax at marginal rate
-
0
59
Taxation charge in the financial statements
174,893
67,416

In addition to the amount charged to the profit and loss account, the following amounts relating to tax have been recognised directly in other comprehensive income:

2025
2024
£
£
Deferred tax arising on:
Revaluation of property
-
(231,649)
9
Dividends
2025
2024
£
£
Interim paid
340,000
-
0
EAST AND WEST HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 20 -
10
Tangible fixed assets
Land and buildings Freehold
Fixtures, fittings & equipment
Motor vehicles
Total
£
£
£
£
Cost or valuation
At 1 June 2024
5,000,000
875,361
-
0
5,875,361
Additions
-
0
58,097
16,000
74,097
At 31 May 2025
5,000,000
933,458
16,000
5,949,458
Depreciation and impairment
At 1 June 2024
-
0
637,581
-
0
637,581
Depreciation charged in the year
-
0
91,342
667
92,009
At 31 May 2025
-
0
728,923
667
729,590
Carrying amount
At 31 May 2025
5,000,000
204,535
15,333
5,219,868
At 31 May 2024
5,000,000
237,780
-
0
5,237,780

Land and buildings with a carrying amount of £5,000,000 were revalued at 21 August 2023 by Christie & Co , independent valuers not connected with the company on the basis of market value. The valuation conforms to International Valuation Standards and was based on recent market transactions on arm's length terms for similar properties.

 

No independent valuation was carried out at the year ended 31 May 2025, but the Directors do not believe there has been a significant movement in value since the last valuation performed.

 

Land and buildings are carried at valuation. If land and buildings were measured using the cost model, the carrying amounts would have been approximately £2,897,560 (2024 - £2,897,560), being cost £3,389,479 (2024 - £3,389,479) and depreciation £491,919 (2024 - £491,919).

11
Stocks
2025
2024
£
£
Finished goods and goods for resale
9,165
9,421
12
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
871,182
1,098,473
Other debtors
-
0
20,000
Prepayments and accrued income
70,538
52,852
941,720
1,171,325
EAST AND WEST HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 21 -
13
Creditors: amounts falling due within one year
2025
2024
Notes
£
£
Bank loans
15
66,356
315,972
Trade creditors
409,299
300,557
Corporation tax
233,568
80,865
Other taxation and social security
399,235
612,451
Other creditors
322,617
281,314
Accruals and deferred income
215,086
193,720
1,646,161
1,784,879
14
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Bank loans and overdrafts
15
1,428,142
1,242,078
15
Loans and overdrafts
2025
2024
£
£
Bank loans
1,494,498
1,558,050
Payable within one year
66,356
315,972
Payable after one year
1,428,142
1,242,078

The bank loan is secured by way of debenture and legal charges over the properties owned by the company.

 

16
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company:

Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
35,774
40,624
Revaluations
402,630
402,630
438,404
443,254
EAST AND WEST HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
16
Deferred taxation
(Continued)
- 22 -
2025
Movements in the year:
£
Liability at 1 June 2024
443,254
Credit to profit or loss
(4,850)
Liability at 31 May 2025
438,404
17
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
80,507
64,425

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

18
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
16,500
16,500
16,500
16,500
19
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2025
2024
£
£
Within 1 year
61,178
61,178
Years 2-5
5,945
19,553
67,123
80,731
20
Capital commitments

Amounts contracted for but not provided in the financial statements:

2025
2024
£
£
Acquisition of tangible fixed assets
151,000
-
EAST AND WEST HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MAY 2025
- 23 -
21
Cash generated from operations
2025
2024
£
£
Profit after taxation
494,430
202,010
Adjustments for:
Taxation charged
174,893
67,416
Finance costs
123,005
161,410
Depreciation and impairment of tangible fixed assets
92,009
91,492
Movements in working capital:
Decrease/(increase) in stocks
256
(916)
Decrease in debtors
229,605
148,537
Decrease in creditors
(41,805)
(427,079)
Cash generated from operations
1,072,393
242,870
22
Analysis of changes in net debt
1 June 2024
Cash flows
31 May 2025
£
£
£
Cash at bank and in hand
570,416
444,699
1,015,115
Borrowings excluding overdrafts
(1,558,050)
63,552
(1,494,498)
(987,634)
508,251
(479,383)
2025-05-312024-06-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.100Miss N ChoudhryMiss N AliMiss R Khan042097092024-06-012025-05-3104209709bus:Director12024-06-012025-05-3104209709bus:Director22024-06-012025-05-3104209709bus:Director32024-06-012025-05-3104209709bus:RegisteredOffice2024-06-012025-05-31042097092025-05-31042097092023-06-012024-05-3104209709core:RetainedEarningsAccumulatedLosses2023-06-012024-05-3104209709core:RetainedEarningsAccumulatedLosses2024-06-012025-05-3104209709core:RevaluationReserve2024-06-012025-05-3104209709core:RevaluationReserve2023-06-012024-05-3104209709core:RevenueReservesInvestmentFundsOnly2023-06-012024-05-3104209709core:ShareCapital2023-05-3104209709core:SharePremium2023-05-3104209709core:RevaluationReserve2023-05-3104209709core:RetainedEarningsAccumulatedLosses2023-05-3104209709core:ShareCapital2024-05-3104209709core:SharePremium2024-05-3104209709core:RevaluationReserve2024-05-3104209709core:RetainedEarningsAccumulatedLosses2024-05-31042097092024-05-3104209709core:ShareCapital2025-05-3104209709core:SharePremium2025-05-3104209709core:RevaluationReserve2025-05-3104209709core:RetainedEarningsAccumulatedLosses2025-05-3104209709core:ShareCapitalOrdinaryShareClass12025-05-3104209709core:ShareCapitalOrdinaryShareClass12024-05-310420970912024-06-012025-05-310420970912023-06-012024-05-31042097092024-05-31042097092023-05-3104209709core:LandBuildingscore:OwnedOrFreeholdAssets2025-05-3104209709core:FurnitureFittings2025-05-3104209709core:MotorVehicles2025-05-3104209709core:LandBuildingscore:OwnedOrFreeholdAssets2024-05-3104209709core:FurnitureFittings2024-05-3104209709core:MotorVehicles2024-05-3104209709core:CurrentFinancialInstrumentscore:WithinOneYear2025-05-3104209709core:CurrentFinancialInstrumentscore:WithinOneYear2024-05-3104209709core:Non-currentFinancialInstrumentscore:AfterOneYear2025-05-3104209709core:Non-currentFinancialInstrumentscore:AfterOneYear2024-05-3104209709core:LandBuildingscore:OwnedOrFreeholdAssets2024-06-012025-05-3104209709core:FurnitureFittings2024-06-012025-05-3104209709core:MotorVehicles2024-06-012025-05-3104209709core:UKTax2024-06-012025-05-3104209709core:UKTax2023-06-012024-05-3104209709core:LandBuildingscore:OwnedOrFreeholdAssets2024-05-3104209709core:FurnitureFittings2024-05-3104209709core:MotorVehicles2024-05-3104209709core:CurrentFinancialInstruments2025-05-3104209709core:CurrentFinancialInstruments2024-05-3104209709core:Non-currentFinancialInstruments2025-05-3104209709core:Non-currentFinancialInstruments2024-05-3104209709core:WithinOneYear2025-05-3104209709core:WithinOneYear2024-05-3104209709bus:OrdinaryShareClass12024-06-012025-05-3104209709bus:OrdinaryShareClass12025-05-3104209709bus:OrdinaryShareClass12024-05-3104209709core:BetweenTwoFiveYears2025-05-3104209709core:BetweenTwoFiveYears2024-05-3104209709bus:PrivateLimitedCompanyLtd2024-06-012025-05-3104209709bus:FRS1022024-06-012025-05-3104209709bus:Audited2024-06-012025-05-3104209709bus:FullAccounts2024-06-012025-05-31xbrli:purexbrli:sharesiso4217:GBP